Psychotropic medications and mitochondrial toxicity
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many psychotropics have detrimental effects on the mitochondria and hence may not be deemed suitable for use in these patients. 9”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [9]
In the citing paper
“Many classes of psychotropic medications are found in‐vitro to negatively affect mitochondrial function by inhibiting mitochondrial respiratory chain, 9 , 10”
From Psychiatric care for a person with MELAS syndrome: A case report (2021) · cites this paper as [9]
Citations
Cites
Impaired mitochondrial function in psychiatric disorders
Manji, H., Kato, T., Di Prospero, N. A., Ness, S., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3229 · Cited by 483
Neuroleptic medications inhibit complex I of the electron transport chain
Burkhardt, C., Kelly, J. P., Lim, Y., Filley, C. M., & Parker, W. D. (1993) · Annals of Neurology · doi:10.1002/ana.410330516 · Cited by 219
The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature
Anglin, R. E., Garside, S. L., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07237 · Cited by 150
Self-citationEffect of fluoxetine on rat liver mitochondria
Souza, M. E. J., Polizello, A. C. M., Uyemura, S. A., Castro-Silva, O., & Curti, C. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90283-6 · Cited by 95
Inhibitory effects of sodium valproate on oxidative phosphorylation
Haas, R., Chir, B., Stumpf, D. A., Parks, J. K., & Eguren, L. (1981) · Neurology · doi:10.1212/wnl.31.11.1473 · Cited by 95
Differential effects of typical and atypical neuroleptics on mitochondrial functionin vitro
Modica-Napolitano, J. S., Lagace, C. J., Brennan, W. A., & Aprille, J. R. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02980205 · Cited by 92
Casademont, J., Garrabou, G., Miró, Ò., López, S., Pons, A., Bernardo, M., & Cardellach, F. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318054753e · Cited by 81
The Psychiatric Presentation of Mitochondrial Disorders in Adults
Anglin, R. E., Tarnopolsky, M. A., Mazurek, M. F., & Rosebush, P. I. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11110345 · Cited by 77
Self-citationCurti, C., Mingattao, F. E., Polizello, A. C. M., Galastri, L. O., Uyemura, S. A., & Santos, A. C. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006912010550 · Cited by 74
Ponchaut, S., & Veitch, K. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90404-k · Cited by 63
Cited by
Our (Mother’s) Mitochondria and Our Mind
Krämer, P., & Bressan, P. (2017) · Perspectives on Psychological Science · doi:10.1177/1745691617718356 · Cited by 101
Eftekhari, A., Ahmadian, E., Azarmi, Y., Parvizpur, A., Fard, J. K., & Eghbal, M. A. (2018) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-018-1724-6 · Cited by 64
Mitochondria dysfunction and bipolar disorder: From pathology to therapy
Lam, X.-J., Xu, B., Yeo, P. L., Cheah, P.-S., & Ling, K. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.04.002 · Cited by 60
Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
Huang, Y., & Zhou, B. (2023) · Biomedicines · doi:10.3390/biomedicines11051500 · Cited by 45
Neuropsychiatric Features in Primary Mitochondrial Disease
Marin, S. E., & Saneto, R. P. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.08.011 · Cited by 27
“Some authors have suggested that the dissimilar findings in post mortem studies may result from changes in complex activity with delay post mortem or may be the effects of different patterns in antipsychotic use in patients with schizophrenia.(299,300) Further studies are warranted to determine if any consistent patte…”
BackgroundSeo, Y., Bang, S., Son, J., Kim, D., Jeong, Y., Kim, P., Yang, J.-H., Eom, J.-H., Choi, N., & Kim, H. N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.009 · Cited by 24
“Traditionally, researchers have evaluated drug toxicity using 2D in vitro and in vivo models [5 – 7].”
BackgroundMental illness in patients with inherited mitochondrial disorders
Rosebush, P. I., Anglin, R., Rasmussen, S. A., & Mazurek, M. F. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.010 · Cited by 21
Self-citationPsychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models
Holper, L., Ben‐Shachar, D., & Mann, J. J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.06.010 · Cited by 20
Health system support among patients with ME/CFS in Switzerland
Tschopp, R., König, R. S., Rejmer, P., & Paris, D. H. (2023) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.12.019 · Cited by 18
Rapinesi, C., Janiri, D., Kotzalidis, G. D., Serata, D., CASALE, A. D., Scatena, P., Dacquino, C., Gentile, G., Manfredi, G., Danese, E., et al. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.002 · Cited by 7
Adverse effect propensity: A new feature of Gulf War illness predicted by environmental exposures
Golomb, B. A., & Han, J. (2023) · iScience · doi:10.1016/j.isci.2023.107363 · Cited by 6
Eftekhari, A., Ahmadian, E., Azarmi, Y., Parvizpur, A., Fard, J. K., & Eghbal, M. A. (2018) · PubMed Central · Cited by 4
Psychiatric care for a person with MELAS syndrome: A case report
Leong, D. Y., Chee, R. Y., & Lui, Y. S. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4146 · Cited by 2
Psychiatric Implications of Mitochondrial Disorders
Farkas, G. I. (2016) · American Journal of Psychiatry Residents' Journal · doi:10.1176/appi.ajp-rj.2016.110705 · Cited by 2
Triantos, C. K., Kalafateli, M., Aggeletopoulou, I., Mandellou, M., Assimakopoulos, S. F., Tselekouni, P., Taprantzi, D., Tsiaoussis, G. I., Vourli, G., Anastassiou, E. D., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000924 · Cited by 2
Holper, L., Ben‐Shachar, D., & Mann, J. J. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3235666 · Cited by 1
The Mechanism of D2R Overactivation in Neurite Impairment and Oxidative Stress
Zheng, P. (2020) · Research Online (University of Wollongong)
Shaju, A., Mishra, B. R., Mohapatra, D., Mishra, A., Srinivasan, A., & Maiti, R. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261453937
“…both typical and atypical antipsychotics can inhibit MRCC I, thereby impairing mitochondrial respiration independent of their dopaminergic effects (Anglin et al., 2012; Burkhardt et al., 1993; Chan et al., 2020; Hardy et al., 2023; Luptak et al., 2021; Modica-Napolitano et al., 2003; Prince et…”
Metadata
- Authors
- Anglin, R., Rosebush, P., & Mazurek, M.
- Affiliations
- McMaster University (CA)
- Corresponding author
- Anglin, Rebecca
- Venue
- Nature Reviews Neuroscience
- Published
- 2012-07-25
- Volume
- 13
- Issue
- 9
- Pages
- 650-650
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2046027437
- Cited by
- 17
- References
- 10
- Citations by year
- 2026: 1 · 2023: 4 · 2021: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- psychotropic drugs, mitochondrial toxicity, mitochondrial dysfunction, antipsychotic drugs, valproic acid, fluoxetine, electron transport chain, mitochondrial complex I inhibition, oxidative phosphorylation, F1F0-ATPase, mental illness, atypical antipsychotics, lithium toxicity, oxidative stress, neurodegeneration, neuroleptic-induced parkinsonism
- MeSH terms
- Animals, Mental Disorders, Energy Metabolism, Humans, Mitochondria, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.